A new, non-invasive knee procedure could bring some relief for patients suffering from debilitating chronic knee pain, for whom surgery is not an option. The Physicians of Orthopedic Pain Specialists were instrumental in the clinical trial of Coolief for Knee Pain that led to the FDA approval.
The treatment, recently approved by the Food and Drug Administration, is called “cooled radio frequency ablation” and is a less drastic option for people with moderate to severe osteoarthritis knee pain who are not ready to have knee replacement surgery, or who have health conditions that don’t make them a good candidate for surgery.
“I see many patients who suffer with chronic osteoarthritis knee pain in my practice who are not immediate candidates for knee replacement surgery due to co-morbidities, such as obesity or other chronic health issues,” said Dr. Timothy Davis, founder and medical director, Orthopedic Pain Specialists, and investigator in the recent study. “COOLIEF Cooled RF treatment provides significant pain relief for patients with OA of the knee until they are able to undergo surgery. Until now there have been few options available for my patients.”
According to the Centers for Disease Control and Prevention, OA affects over 30 million adults in the U.S. and is caused by the damage and breakdown of cartilage between bones that can lead to joint pain, swelling and stiffness3. The prevalence of OA is on the rise as both the age and weight of Americans continue to increase4. As cases of OA increase, so do associated economic costs including treatment, adaptation of lives and homes to help patients manage pain caused by the disease, and lost work productivity5. Click Here To see the Full Press Release on the FDA approval of “Coolief”